Vanguard Research Group赞助的临床试验
总计1337个结果
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia Group B; North... 和其他合作者完全的
-
The Young Investigator Group of Cardiovascular...招聘中
-
Cantargia ABSpanish Breast Cancer Research Group招聘中
-
RWTH Aachen UniversityOptimal@NRW Research Group招聘中
-
Cassava Sciences, Inc.Premier Research Group plc主动,不招人
-
RWTH Aachen UniversityOptimal@NRW Research Group完全的
-
Spanish Breast Cancer Research GroupNovartis Pharmaceuticals完全的
-
Japan Breast Cancer Research GroupChugai Pharmaceutical完全的
-
Tonix Pharmaceuticals, Inc.Premier Research Group plc主动,不招人
-
InnocollDuke University; Premier Research Group plc完全的
-
InnocollDuke University; Premier Research Group plc完全的
-
Perseverance Research Center, LLCAthena Medical Group未知
-
Wex Pharmaceuticals Inc.Premier Research Group plc终止
-
Genentech, Inc.SOLTI Breast Cancer Research Group完全的
-
Encore Medical Inc.Bright Research Partners; Yale Cardiovascular Research Group招聘中
-
Canadian Scleroderma Research GroupCanadian Institutes of Health Research (CIHR)未知
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中肛门基底细胞癌 | 肛管泄殖腔癌 | 肛管鳞状细胞癌 | 肛缘鳞状细胞癌 | I 期肛门癌 AJCC v8 | IIA 期肛门癌 AJCC v8美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌 | III期乳腺癌美国, 南非
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人骨髓增生异常综合征后伴多系发育不良的急性髓系白血病 | 成人急性巨核细胞白血病 (M7) | 成人急性微分化髓性白血病 (M0) | 成人急性单核细胞白血病 (M5a) | 成人急性单核细胞白血病 (M5b) | 成熟型成人急性成髓细胞白血病 (M2) | 未成熟的成人急性成髓细胞白血病 (M1) | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 成人急性粒单核细胞白血病 (M4) | 成人红白血病 (M6a) | 成人纯红细胞白血病... 及其他条件美国, 以色列, 印度
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)终止
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)终止
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)终止黑色素瘤 | 恶性黑色素瘤
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人去势抵抗性前列腺癌 | 软组织转移性前列腺癌 | IV 期前列腺腺癌 AJCC v7 | 睾酮的去势水平 | 前列腺癌骨转移美国, 波多黎各
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group主动,不招人
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); ECOG-ACRIN Cancer Research Group撤销胃肠癌 | 胃食管连接部腺癌 | IV 期胃癌 | 食管腺癌 | IV 期食管癌 | 胃弥漫性腺癌 | 胃肠腺癌 | 胃混合性腺癌 | IIIA期胃癌 | IIIB期胃癌 | IIIC期胃癌 | IIIA期食管癌 | IIIB期食道癌 | IIIC 期食管癌美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)撤销
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的多发性骨髓瘤和浆细胞肿瘤
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的